# Clinical Study of Taurine Combined With Sintilimab and Chemotherapy for Treatment of Advanced Gastric Cancer

> **NCT06123455** · PHASE2 · UNKNOWN · sponsor: **Tang-Du Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** Taurine
- **BIOLOGICAL:** Sintilimab
- **DRUG:** XELOX regimen
- **DRUG:** SOX regimen
- **DRUG:** FOLFOX regimen

## Key facts

- **NCT ID:** NCT06123455
- **Lead sponsor:** Tang-Du Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08-01
- **Primary completion:** 2025-07-31
- **Final completion:** 2025-07-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06123455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06123455, "Clinical Study of Taurine Combined With Sintilimab and Chemotherapy for Treatment of Advanced Gastric Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06123455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*